Rock Edwin

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$725,580.64
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Rock Edwin

According to the SEC Form 4 filings, Rock Edwin, being in a position of

  1. Chief Medical Officer at GlycoMimetics, Inc.,
    оver the last 12 months, has bought 305000 shares for $78,825, and sold 0 shares,
    over all time since 2022-11-14, has bought 680403 shares for $725,581, and sold 0 shares.

The largest purchase of all time was on 2022-12-22 and amounted to 110000 shares of GlycoMimetics, Inc. for $247,500.

Biography of Rock Edwin

No biography is available at this moment.

2024-06-21PurchaseGlycoMimetics, Inc.
GLYC
Chief Medical Officer
115,000
0.1787%
$0.27$30,717-33.85%
2024-06-20PurchaseGlycoMimetics, Inc.
GLYC
Chief Medical Officer
190,000
0.2799%
$0.25$48,108-31.32%
2023-09-22PurchaseGlycoMimetics, Inc.
GLYC
Chief Medical Officer
30,403
0.0463%
$1.38$41,956+6.38%
2023-09-21PurchaseGlycoMimetics, Inc.
GLYC
Chief Medical Officer
35,000
0.0544%
$1.38$48,300+8.7%
2022-12-22PurchaseGlycoMimetics, Inc.
GLYC
Chief Medical Officer
110,000
0.2068%
$2.25$247,500-29.2%
2022-11-15PurchaseGlycoMimetics, Inc.
GLYC
Chief Medical Officer
100,000
0.1844%
$1.66$166,000-4.12%
2022-11-14PurchaseGlycoMimetics, Inc.
GLYC
Chief Medical Officer
100,000
0.1862%
$1.43$143,000+12.76%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.